VP at MedImmune to Speak at Cytokines Conference Jan 31, 2013 in San Diego, CA

Tomas Mustelin, Vice President of Research, Respiratory, Inflammatory, and Autoimmune Diseases at MedImmune Will Give a Featured Presentation at the 11th Cytokines and Inflammation Conference (Jan 31-Feb 1, 2013 in San Diego, CA)

Tomas Mustelin, Vice President of Research, Respiratory, Inflammatory, and Autoimmune Diseases at MedImmune will give a featured presentation on “Targeting Cytokines in the Appropriate Patient Subsets” at the 11th Cytokines and Inflammation Conference to be held in San Diego, CA on January 31 – February 1, 2013 by GTC.

Dr. Mustelin is Vice President and Interim Head of Research at MedImmune. On top of his many responsibilities, he oversees departments for novel therapeutics for grievous respiratory, inflammatory, and autoimmune diseases. He is currently a member of the UCSD Clinical and Translational Research Institute (CTRI) and is interested in opportunities for clinical and translational collaborations. Dr. Mustelin is also an Adjunct Professor at both Burnham Institute and UCSD.

Prior to MedImmune, Dr. Mustelin was Vice President and Site Head of Amgen from 2007 to 2011 where he delivered 11 novel therapeutics into clinical trials. From 1999 to 2007, he was Professor at Burnham Institute and lead an independent, NIH-funded, research group of up to 25 scientists in many areas of cell biology, immunology, cancer, HTS and drug discovery, genetics, genomics, and nanotechnology. In 1999, he was also Professor at Sidney Kimmel Cancer Center where he led another independent, NIH-funded, research group focusing on signal transduction, kinases, phosphatases, in immunity and cancer.

The GTC Cytokines and Inflammation conferences have become an established meeting point for academic scientists and industry clinical developers to exchange their complementary approaches in the field of cytokine biology. The organizations participating are a great selection of innovative medical organizations from academia (City of Hope, NCI, NIH, USC, Sanford-Burnham, Cleveland Clinic, UCLA, University of Florida, etc.), industry (Amgen, Bristol-Myers Squibb, Genentech, HUMIGEN, MedImmune, Biogen Idec, Merck Serono, Novo Nordisk, etc.) and, last but not -by any means- least, the US FDA.

This conference is also part of the 2nd Novel Immunotherapeutics Summit, which consists of a workshop, this track and three other concurrent tracks:
1) 5th Immunotherapeutics & Immunomonitoring
2) 2nd Allergy & Respiratory Drug Discovery
3) Immunotoxicity & Immunogenicity
4) Workshop: Immune Responses in Tumor Microenvironment

For more information, please visit www.gtcbio.com

Contact Details

Company Name: GTC Conferences
Issued By: Eileen Zhao
Phone: 6262566405
Address: Global Technology Community | 635 W. Foothill Blvd | Monrovia, CA 91016
City: San Diego
State: California
Zip: 91016
Country: United States
Website: Visit the website

Keywords : cytokines,

by Eileen Zhao (few years ago!)

Latest Press Releases

The Mad Hatter Now Offer a Full Line of Hearth Products and Full Line of Grills

Diabetes Insulin Delivery Pens Market Research Report 2018

Dr Kapadia Provides Tips to Patients Interested in Hair Transplant Procedures

love vashikaran specialist

Solar Blanket Sales Market Report 2018

Spring Bottled Water Market Insights, Forecast to 2025

Biochemical Incubator Sales Market Report 2018

Quinine Sulphate Sales Market Report 2018

Automotive Chassisc System Market Insights, Forecast to 2025

2,6-Dicarboxypyridine market size in key regions like North America, Europe, Asia Pacific an..

Remove this press release ?

Due to extra work required to remove the press-releases we have started charging $1.99 for press release removal.

Your press release will be removed in 24 hours, once the payment has been received.

Search Press Release
e.g. Business, Computer, etc.